These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 8799409)

  • 1. Effect of percutaneous ethanol injection for postoperative recurrence of hepatocellular carcinoma in combination with transcatheter arterial embolization.
    Ishii H; Okada S; Sato T; Nose H; Okusaka T; Yoshimori M; Takayasu K; Takayama T; Kosuge T; Yamasaki S
    Hepatogastroenterology; 1996; 43(9):644-50. PubMed ID: 8799409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
    Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M
    Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy with transcatheter arterial embolization and percutaneous ethanol injection for advanced hepatocellular carcinoma.
    Koda M; Okamoto K; Miyoshi Y; Kato S; Murawaki Y; Horie Y; Suou T; Kawasaki H
    Hepatogastroenterology; 1994 Feb; 41(1):25-9. PubMed ID: 8175109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy for large hepatocellular carcinoma combined with transcatheter arterial embolization and percutaneous ethanol injection therapy.
    Yasuda S; Ito H; Yoshikawa M; Shinozaki M; Goto N; Fujimoto H; Nasu K; Uno T; Itami J; Isobe K; Shigematsu N; Ebara M; Saisho H
    Int J Oncol; 1999 Sep; 15(3):467-73. PubMed ID: 10427126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for recurrence of large HCC in patients treated by combined TAE and PEI.
    Arata S; Tanaka K; Okazaki H; Kondo M; Morimoto M; Saito S; Numata K; Nakamura S; Sekihara H
    Hepatogastroenterology; 2001; 48(38):480-5. PubMed ID: 11379338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and treatment for recurrent hepatocellular carcinoma].
    Yoshikawa M; Ebara M; Fukuda H; Sugiura N; Saisho H
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):327-32. PubMed ID: 9492824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of transcatheter arterial embolization and percutaneous ethanol injection for hepatocellular carcinoma: comparison of efficacies of doxorubicin and epirubicin in transcatheter arterial embolization.
    Nakamura S; Tanaka K
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-46-S6-49. PubMed ID: 9151916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodality treatment for patients with hepatocellular carcinoma: a single institution retrospective series.
    Takano S; Watanabe Y; Ohishi H; Kono S; Nakamura M; Kubota N; Iwai S
    Eur J Surg Oncol; 2000 Feb; 26(1):67-72. PubMed ID: 10718183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indication of chemoembolization therapy without gelatin sponge for hepatocellular carcinoma.
    Suzuki M; Suzuki H; Yamamoto T; Mamada Y; Mizuno H; Tominaga T; Suga M; Suemori S; Kato Y; Sato A; Yamanouchi E; Sakuyama K; Maeyama S; Shinagawa T; Okabe K
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-110-S6-115. PubMed ID: 9151925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center.
    Ueno S; Tanabe G; Nuruki K; Oketani M; Komorizono Y; Hokotate H; Fukukura Y; Baba Y; Imamura Y; Aikou T
    J Hepatobiliary Pancreat Surg; 2002; 9(4):469-77. PubMed ID: 12483269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of percutaneous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that of hepatectomy.
    Kotoh K; Sakai H; Sakamoto S; Nakayama S; Satoh M; Morotomi I; Nawata H
    Am J Gastroenterol; 1994 Feb; 89(2):194-8. PubMed ID: 8304302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
    Dohmen K; Shirahama M; Shigematsu H; Miyamoto Y; Torii Y; Irie K; Ishibashi H
    Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Radiofrequency ablation and percutaneous ethanol injection in patients with unresectable hepatocellular carcinoma--a comparative study using Japan Integrated Staging Score (JIS score) system].
    Morimoto M; Numata K; Sugimori K; Shirato K; Kokawa A; Oka H; Hirao M; Hirasawa K; Ko R; Saitou T; Imada T; Tanaka K
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1592-5. PubMed ID: 16315880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in resected hepatocellular carcinomas and therapeutic value of transcatheter arterial embolization for recurrences.
    Kimura H; Yabushita K; Konishi K; Maeda K; Kuroda Y; Tsuji M; Demachi H; Miwa A
    Int Surg; 1998; 83(2):146-9. PubMed ID: 9851333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
    Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma.
    Peng ZW; Zhang YJ; Chen MS; Liang HH; Li JQ; Zhang YQ; Lau WY
    Surg Oncol; 2008 Jul; 17(1):23-31. PubMed ID: 17869095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma].
    Chen XM; Luo PF; Lin HH; Zhou ZJ; Shao PJ; Fu L; Li WK
    Ai Zheng; 2004 Jul; 23(7):829-32. PubMed ID: 15248922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of transcatheter arterial embolization therapy for small hepatocellular carcinomas: comparison with other treatments.
    Arai K; Matsui O; Takashima T; Kadoya M; Yoshikawa J; Gabata T; Ueda K; Kawamori Y; Izumi R; Kobayashi K
    Radiat Med; 1990; 8(5):191-8. PubMed ID: 1963696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transcatheter hepatic arterial chemoembolization on recurrent hepatocellular carcinoma after resection].
    Ge NL; Ren ZG; Ye SL; Lin ZY; Xia JL; Gan YH; Li LX; Shen YF; Tang ZY
    Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):380-2. PubMed ID: 16117905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
    Yamagiwa K; Shiraki K; Yamakado K; Mizuno S; Hori T; Yagi S; Hamada T; Iida T; Nakamura I; Fujii K; Usui M; Isaji S; Ito K; Tagawa S; Takeda K; Yokoi H; Noguchi T
    J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.